James McNeely
Optometrist · Greenville, SCNPI 1780877662
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,240 of the $8,686 with a category attached, or 60.3%. 17 manufacturers reported payments, led by Alcon at 44.3% of the total. Reporting peaked in 2023 at $4,247 and has fallen 77.5% since, to $955 in 2025. Among optometrist clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 149 payments — averaging $58.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$4K
- Coopervision Inc.$1K
- Sun Pharmaceutical Industries Inc.$559
- Bausch & Lomb Americas Inc.$503
- Oyster Point Pharma, Inc.$432
- Optos, Inc.$411
- plus $2K from 11 others
What the payments were for
- Speaking & faculty fees$3,07535%
- Food & beverage$5,24060%
- Entertainment$3714%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 26 | $3,850 |
| Coopervision Inc. | 27 | $1,327 |
| Sun Pharmaceutical Industries Inc. | 13 | $559 |
| Bausch & Lomb Americas Inc. | 17 | $503 |
| Oyster Point Pharma, Inc. | 15 | $432 |
| Optos, Inc. | 6 | $411 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 6 | $366 |
| AbbVie(2 entities) | 12 | $268 |
| Biotissue Holdings Inc. | 5 | $200 |
| Maculogix, Inc. | 1 | $197 |
| Shire North American Group Inc | 2 | $112 |
| Regeneron Healthcare Solutions, Inc. | 1 | $92 |
| Johnson & Johnson Vision Care, Inc. | 5 | $92 |
| Novartis | 5 | $83 |
| Tarsus Pharmaceuticals, Inc. | 3 | $77 |
| Harrow Eye, LLC | 3 | $68 |
| Dompe US, Inc. | 2 | $48 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAILIES TOTAL1$3,000
- CEQUA$352
- INFUSE$327
- TOTAL30$251
- MyDay Contact Lens$235
- PANORAMIC OPHTHALMOSCOPE$228
- OCT OPHTHALMOSCOPE$228
- TYRVAYA$214
- AdaptDx$197
- Prokera$129
- AmnioGraft$129
- Rhopressa$125
- Rocklatan$125
- SIMBRINZA$125
- NFC-700$114
- Multiple Brands Contact Lens$105
- P200DTx$100
- P200T$100
- P200TE$100
- P200TxE$100
How this compares
$8,686 in reported general payments places this provider in the 95th percentile of 653 optometrist providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyzultaLatanoprostene Bunod | 27 | $8,062 |
| CombiganBrimonidine Tartrate/Timolol | 13 | $4,124 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 27 | $3,829 |
| Latanoprost | 160 | $1,333 |
| Prednisolone Acetate | 42 | $994 |
| Fluorometholone | 14 | $813 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 48 | $653 |
| Timolol Maleate | 64 | $294 |
| Brimonidine Tartrate | 17 | $68 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Vyzulta | $503 | $8,06227 claims |
| AbbVieCombigan | $268 | $4,12413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 653 optometrist providers in South Carolina.
Other optometrist in Greenville
- Steven AndreasenGreenville$19K
- Bridget WhaleyGreenville$18K
- Milan LockhartGreenville$11K
- William BallingerGreenville$8K
- Justine OdellGreenville$7K
- Johndra McNeelyGreenville$7K
- Charles PickensGreenville$6K
- Randall BaughmanGreenville$6K
- Daniel HaasGreenville$5K
- William SoutherlandGreenville$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.